Generation Bio Co. (GBIO)
NASDAQ: GBIO · IEX Real-Time Price · USD
2.830
-0.020 (-0.70%)
Apr 30, 2024, 4:00 PM EDT - Market closed

Generation Bio Co. Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020
Market Capitalization
1881092344031,319
Market Cap Growth
--53.31%-42.04%-69.45%-
Enterprise Value
16-63301031,054
PE Ratio
-0.86-0.86-1.71-3.38-16.38
PS Ratio
31.8718.47---
PB Ratio
0.930.540.831.064.92
P/FCF Ratio
-1.81-1.81-2.10-4.13-17.43
P/OCF Ratio
-2.07-2.07-2.28-4.39-18.80
EV/Sales Ratio
2.69-10.71---
EV/EBITDA Ratio
0.520.52-0.23-0.90-13.68
EV/EBIT Ratio
0.500.50-0.22-0.86-13.09
EV/FCF Ratio
1.051.05-0.27-1.05-13.94
Debt / Equity Ratio
0.480.480.290.21-
Debt / EBITDA Ratio
-0.81-0.81-0.62-0.71-
Debt / FCF Ratio
-1.63-1.63-0.73-0.83-
Quick Ratio
6.876.8714.8920.2523.56
Current Ratio
6.836.8314.9920.1623.86
Asset Turnover
0.020.02000
Return on Equity (ROE)
-52.30%-52.30%-43.10%-28.40%-43.30%
Return on Assets (ROA)
-31.80%-31.80%-33.30%-24.50%-30.10%
Return on Capital (ROIC)
-46.03%-46.03%-38.76%-25.75%-30.26%
Earnings Yield
-67.29%-116.13%-58.51%-29.57%-6.11%
FCF Yield
-31.96%-55.16%-47.64%-24.24%-5.74%
Buyback Yield / Dilution
-10.96%-10.96%-3.23%-106.54%-476.06%
Total Shareholder Return
-10.96%-10.96%-3.23%-106.54%-476.06%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).